tirzepatide before and after photos weight loss progress Look at our awesome client's

PCO-02 - Safety and Pharmacokinetics Trial

A team of Virta Health leaders held a webinar on 13th July 2023 to explain the results of a study the company just completed assessing health plan execs current views on Ozempic and other GLP-1 medicines with a view on both clinical outcomes and cost implications for this growing category of drugs that address diabetes and obesity

In propensity-matched analyses, semaglutide treatment was associated with lower rates of several cardiovascular outcomes than treatment with metformin, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodium-glucose cotransporter 2 (SGLT2) inhibitors

GHK-Cu users benefit from documenting non-hair effects that emerge earlier in treatment

A logistic regression analysis of risk factors in ME/CFS pathogenesis

Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning